Zhang Z, Xie T, Wang Y, Shen L, Zhang X, Peng Z. Immune checkpoint inhibitors or anti-claudin 18.2 antibodies? A network meta-analysis for the optimized first-line therapy of HER2-negative gastric cancer. Therapeutic Advances in Medical Oncology. 2024;16. doi:10.1177/17588359241231253
In the above-referenced article, affiliation to the authors Zhening Zhang, Tong Xie, Yingxuan Wang are incorrect. The correct affiliations are as given below:
Zhening Zhang, Tong Xie, and Yingxuan Wang are affiliated to Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Gastrointestinal Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China
Lin Shen, Xiaotian Zhang, and Zhi Peng are affiliated to State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, Department of Gastrointestinal Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China
The online version of the paper has been corrected.